D-1693-2012 Class II Terminated

Recalled by Actavis — Salt Lake City, UT

FDA drug recall D-1693-2012 was initiated by Actavis on Jul 11, 2012 and is designated Class II. Reason for recall: Subpotent; some patches may not contain fentanyl gel The recall status is terminated (terminated Apr 10, 2013). Affected quantity: 98,088 cartons (5 pouches per carton).

Recall details

Product Type
Drugs
Report Date
Oct 3, 2012
Initiation Date
Jul 11, 2012
Termination Date
Apr 10, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
98,088 cartons (5 pouches per carton)

Product description

Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona, CA, Distributed by: Watson, Pharma Inc.

Reason for recall

Subpotent; some patches may not contain fentanyl gel

Distribution pattern

Nationwide

Code information

Lot number 455040A (carton) 455040 (pouch)

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1693-2012
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1693-2012. Report a data issue: hello@regdatalab.com.